Mouse IL-1 beta Pro-form ELISA Ready-SET-Go! **

產品名稱：Mouse IL-1 beta Pro-form ELISA Ready-SET-Go! 2 plates
產品貨號：eBioscience 88-8014-22
產品規格：2 x 96 tests
Mouse IL-1 beta Pro-form ELISA Ready-SET-Go!
Also known as: Interleukin-1 beta, IL-1b, IL-1F2
RUO: For Research Use Only. Not for use in diagnostic procedures.
SKU# 88-8014
Cat. No. Size
88-8014-22  2 x 96 tests w/plates 
88-8014-88  10 x 96 tests 
Description: This Mouse IL-1 beta Pro-form Ready-SET-Go! ELISA Set contains the necessary reagents, standards, buffers and diluents for performing quantitative enzyme-linked immunosorbent assays (ELISA). This ELISA set is specifically engineered for accurate and precise measurement protein levels from samples including serum, plasma, cell lysates, and supernatants from cell cultures. This ELISA set is specific to the pro-form of mouse IL-1 beta and will not detect the active, or cleaved, protein.
Interleukin- 1 beta (IL-1 beta) is a proinflammatory cytokine expressed by monocytes, macrophages, and dendritic cells. It is synthesized in response to inflammatory stimuli as a 31 kDa inactive pro-form that accumulates in the cytosol. Cleavage of pro-IL-1 beta into the active 17 kDa protein requires the activation of inflammasomes, which are multi-protein complexes that respond to pathogens, stress conditions, and other danger signals. Inflammasome activation triggers the processing of the caspase-1 precursor into its active form, which in turn cleaves pro-IL-1 beta. IL-1 beta lacks a signal sequence peptide for classical ER/Golgi pathway and is instead secreted alongside caspase-1 via an alternate and incompletely understood mechanism. Although IL-1 beta is most often secreted in its active form, secretion of the uncleaved protein may be detectable under some biological conditions.
IL-1 beta signals through two receptors, IL-1RI and IL-1RII, both of which are shared with IL-1 alpha. These cytokines play important roles in innate host defense by triggering the production of other proinflammatory cytokines in target cells and initiating acute-phase responses. Their activity can be moderated by IL-1 Receptor Antagonist (IL-1RA), a protein produced by many cell types that blocks receptor binding through competitive inhibition. Elevated levels of IL-1 beta have been associated with many chronic inflammatory conditions, giving IL-RA or IL-1 beta neutralizing antibodies potential therapeutical value.

產品留言

標題

聯系人

聯系電話

內容

驗證碼

點擊換一張

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!
2.如有必要,請您留下您的詳細聯系方式!